August 2020

In a virtual symposium titled Clinical Updates in Extensive-Disease Small Cell Lung Cancer: A Primer for Pharmacists Caring for Patients, 2 expert speakers discussed pivotal changes in the treatment landscape for small cell lung cancer.

In a Pharmacy Times® webcast, Katie Culos, PharmD, BCOP, a specialist in cellular therapy and hematology discussed with Katherine Lin, PharmD, BCPS, BCOP the many policies and procedures that have been implemented during the COVID-19 pandemic by providers for cancer care.

A first-in-class targeted therapy, VB-111 is administered by intravenous infusion once every 6 to 8 weeks.

Many patients battling cancer are in dire need of support, encouragement, and care coordination.

Optimizing the best pharmaceutical agent while minimizing adverse effects is paramount in patients with cancer-associated venous thromboembolism.

Patients may have many questions before receiving CAR T-cell therapy, so accurate counseling is vital to their support.

At the Smilow Cancer Hospital, oncology pharmacists play an important role in the delivery of care for patients with cancer.

A recent study demonstrated the safety and clinical activity of E7 TCR-T cells in the treatment of highly refractory metastatic HPV- 16+ cancers.

Study results have demonstrated that pharmacists are effective partners in improving care, reducing cost, and avoiding drug complications for patients with cancer.

Current advances in the analysis of the mutational status of different genes are providing investigators insights into new treatment pathways that can improve outcomes for patients.

Targeted photodynamic therapy has garnered increasing attention… because of its ability to treat tumors without surgery, chemotherapy, or radiation.

This activity is supported by an educational grant from Merck Sharp & Dohme Corp..

Pharmacists should refer patients to a health care provider if any symptoms could be indicative of a GIST.

Challenges and impact of rare diseases are faced by pharmacy stakeholders.

Patient assistance programs are often the difference between accessing the drug and increasing abandonment rate.

The increasing prevalence of oral oncolytics use, further accelerated by COVID-19, heightens the need for strong patient-pharmacist treatment coordination.

CAR T-cell therapy involves collecting a patient’s blood, extracting the T cells within the blood, and returning the remaining blood back into the body, a process called leukapheresis.

Most women with breast cancer receive treatment post surgery, such as chemotherapy, hormone therapy, and radiation. Targeted therapy is useful against cancers that have spread to distant parts of the body.

By their training, pharmacists are natural problem solvers, and our education has taught us how to use resources to find an answer and often a solution. The world is waiting for a pharmaceutical solution to coronavirus disease 2019 (COVID-19).